Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/326863
Type: Artigo
Title: Evaluation Of The Antineoplastic Activity Of Gallic Acid In Oral Squamous Cell Carcinoma Under Hypoxic Conditions
Author: Guimaraes
Talita A.; Farias
Lucyana C.; Fraga
Carlos A.; Feltenberger
John D.; Melo
Geraldo A.; Coletta
Ricardo D.; Souza Santos
Sergio H.; de Paula
Alfredo M. B.; Guimaraes
Andre L.
Abstract: The purpose of the current study was to develop and test a theoretical model that could explain the mechanism of action of gallic acid (GA) in the oral squamous cell carcinoma context for the first time. The theoretical model was developed using bioinformatics and interaction network analysis to evaluate the effect of GA on oral squamous cell carcinoma. In a second step to confirm theoretical results, migration, invasion, proliferation, and gene expression (Col1A1, E-cadherin, HIF-1, and caspase-3) were performed under normoxic and hypoxic conditions. Our study indicated that treatment with GA resulted in the inhibition of cell proliferation, migration, and invasion in neoplastic cells. Observation of the molecular mechanism showed that GA upregulates E-cadherin expression and downregulates Col1A1 and HIF-1 expression, suggesting that GA might be a potential anticancer compound. In conclusion, the present study demonstrated that GA significantly reduces cell proliferation, invasion, and migration by increasing E-cadherin and repressing Col1A1. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.
Subject: Apoptosis
Caspase-3
Col1a1
E-cadherin
Hif-1 Alpha
Invasion
Migration
Oral Cancer
Proliferation
Editor: Lippincott Williams & Wilkins
Philadelphia
Rights: fechado
Identifier DOI: 10.1097/CAD.0000000000000342
Address: https://insights.ovid.com/pubmed?pmid=26849170
Date Issue: 2016
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
000374759400004.pdf444.19 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.